Tyler J. Curiel - Publications

Baylor University, Waco, TX 
Immunology, Biomedical Engineering, Cell Biology

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Dao V, Liu Y, Pandeswara S, Svatek RS, Gelfond JA, Liu A, Hurez V, Curiel TJ. Immune stimulatory effects of rapamycin are mediated by stimulation of antitumor γδ T cells. Cancer Research. PMID 27569211 DOI: 10.1158/0008-5472.CAN-16-0091  0.36
2016 Massard C, Gordon MS, Sharma S, Rafii S, Wainberg ZA, Luke J, Curiel TJ, Colon-Otero G, Hamid O, Sanborn RE, O'Donnell PH, Drakaki A, Tan W, Kurland JF, Rebelatto MC, et al. Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269937 DOI: 10.1200/JCO.2016.67.9761  0.36
2016 Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Curiel T, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6  0.36
2015 Hurez V, Dao V, Liu A, Pandeswara S, Gelfond J, Sun L, Bergman M, Orihuela CJ, Galvan V, Padrón Á, Drerup J, Liu Y, Hasty P, Sharp ZD, Curiel TJ. Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice. Aging Cell. PMID 26315673 DOI: 10.1111/Acel.12380  0.36
2015 Christy B, Demaria M, Campisi J, Huang J, Jones D, Dodds SG, Williams C, Hubbard G, Livi CB, Gao X, Weintraub S, Curiel T, Sharp ZD, Hasty P. p53 and rapamycin are additive. Oncotarget. PMID 26158292  0.36
2015 Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, Curiel TJ, de Cabo R, Franceschi C, Gems D, Ingram DK, Johnson TE, Kennedy BK, Kenyon C, Klein S, et al. Interventions to Slow Aging in Humans: Are We Ready? Aging Cell. 14: 497-510. PMID 25902704 DOI: 10.1111/Acel.12338  0.36
2015 Dao V, Pandeswara S, Liu Y, Hurez V, Dodds S, Callaway D, Liu A, Hasty P, Sharp ZD, Curiel TJ. Prevention of carcinogen and inflammation-induced dermal cancer by oral rapamycin includes reducing genetic damage. Cancer Prevention Research (Philadelphia, Pa.). 8: 400-9. PMID 25736275 DOI: 10.1158/1940-6207.CAPR-14-0313-T  0.36
2015 Svatek RS, Zhao XR, Morales EE, Jha MK, Tseng TY, Hugen CM, Hurez V, Hernandez J, Curiel TJ. Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 303-11. PMID 25424854 DOI: 10.1158/1078-0432.CCR-14-1781  0.36
2014 Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Lotan Y, Skinner EC, Tilki D, Ficarra V, Volkmer BG, Isbarn H, ... ... Curiel TJ, et al. Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology. 83: 863-7. PMID 24485993 DOI: 10.1016/J.Urology.2013.10.060  0.36
2014 Hasty P, Livi CB, Dodds SG, Jones D, Strong R, Javors M, Fischer KE, Sloane L, Murthy K, Hubbard G, Sun L, Hurez V, Curiel TJ, Sharp ZD. eRapa restores a normal life span in a FAP mouse model. Cancer Prevention Research (Philadelphia, Pa.). 7: 169-78. PMID 24282255 DOI: 10.1158/1940-6207.Capr-13-0299  0.36
2013 Brumlik MJ, Pandeswara S, Ludwig SM, Jeansonne DP, Lacey MR, Murthy K, Daniel BJ, Wang RF, Thibodeaux SR, Church KM, Hurez V, Kious MJ, Zhang B, Alagbala A, Xia X, ... Curiel TJ, et al. TgMAPK1 is a Toxoplasma gondii MAP kinase that hijacks host MKK3 signals to regulate virulence and interferon-γ-mediated nitric oxide production. Experimental Parasitology. 134: 389-99. PMID 23541881 DOI: 10.1016/j.exppara.2013.03.016  0.36
2013 Hasty P, Sharp ZD, Curiel TJ, Campisi J. mTORC1 and p53: clash of the gods? Cell Cycle (Georgetown, Tex.). 12: 20-5. PMID 23255104 DOI: 10.4161/cc.22912  0.36
2013 Sharp ZD, Curiel TJ, Livi CB. Chronic mechanistic target of rapamycin inhibition: Preventing cancer to delay aging, or vice versa? Cancer and Aging: From Bench to Clinics. 38: 1-16. DOI: 10.1159/000343625  0.36
2013 Mahalingam D, Brumlik MJ, Waehler R, Curiel DT, Curiel TJ. Targeted toxins in cancer immunotherapy Cancer Immunotherapy: Paradigms, Practice and Promise. 2147483647: 377-396. DOI: 10.1007/978-1-4614-4732-0_12  0.36
2012 Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. The Journal of Steroid Biochemistry and Molecular Biology. 132: 186-93. PMID 22634477 DOI: 10.1016/J.Jsbmb.2012.05.004  0.36
2012 Hurez V, Daniel BJ, Sun L, Liu AJ, Ludwig SM, Kious MJ, Thibodeaux SR, Pandeswara S, Murthy K, Livi CB, Wall S, Brumlik MJ, Shin T, Zhang B, Curiel TJ. Mitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice. Cancer Research. 72: 2089-99. PMID 22496463 DOI: 10.1158/0008-5472.CAN-11-3019  0.36
2012 Ménétrier-Caux C, Curiel T, Faget J, Manuel M, Caux C, Zou W. Targeting regulatory T cells. Targeted Oncology. 7: 15-28. PMID 22327882 DOI: 10.1007/s11523-012-0208-y  0.36
2011 Brumlik MJ, Pandeswara S, Ludwig SM, Murthy K, Curiel TJ. Parasite mitogen-activated protein kinases as drug discovery targets to treat human protozoan pathogens. Journal of Signal Transduction. 2011: 971968. PMID 21637385 DOI: 10.1155/2011/971968  0.36
2011 Brumlik MJ, Nkhoma S, Kious MJ, Thompson GR, Patterson TF, Siekierka JJ, Anderson TJ, Curiel TJ. Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication. Experimental Parasitology. 128: 170-5. PMID 21338604 DOI: 10.1016/j.exppara.2011.02.016  0.36
2011 Rhodes LV, Short SP, Neel NF, Salvo VA, Zhu Y, Elliott S, Wei Y, Yu D, Sun M, Muir SE, Fonseca JP, Bratton MR, Segar C, Tilghman SL, Sobolik-Delmaire T, ... ... Curiel TJ, et al. Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. Cancer Research. 71: 603-13. PMID 21123450 DOI: 10.1158/0008-5472.Can-10-3185  0.36
2010 Lin PY, Sun L, Thibodeaux SR, Ludwig SM, Vadlamudi RK, Hurez VJ, Bahar R, Kious MJ, Livi CB, Wall SR, Chen L, Zhang B, Shin T, Curiel TJ. B7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses. Journal of Immunology (Baltimore, Md. : 1950). 185: 2747-53. PMID 20686128 DOI: 10.4049/jimmunol.1000496  0.36
2010 Tomihara K, Guo M, Shin T, Sun X, Ludwig SM, Brumlik MJ, Zhang B, Curiel TJ, Shin T. Antigen-specific immunity and cross-priming by epithelial ovarian carcinoma-induced CD11b(+)Gr-1(+) cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 6151-60. PMID 20427766 DOI: 10.4049/jimmunol.0903519  0.36
2010 Jin D, Fan J, Wang L, Thompson LF, Liu A, Daniel BJ, Shin T, Curiel TJ, Zhang B. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression. Cancer Research. 70: 2245-55. PMID 20179192 DOI: 10.1158/0008-5472.CAN-09-3109  0.36
2010 Daniel BJ, Pandeswara S, Brumlik MJ, Liu A, Thibodeaux SR, Ludwig SM, Sun X, Curiel TJ. A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo. Journal of Immunological Methods. 355: 86-90. PMID 20149795 DOI: 10.1016/j.jim.2010.01.013  0.36
2009 Ruter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. Altering regulatory T cell function in cancer immunotherapy: a novel means to boost the efficacy of cancer vaccines. Frontiers in Bioscience (Landmark Edition). 14: 1761-70. PMID 19273160 DOI: 10.2741/3338  0.36
2008 Wei S, Curiel T, Coukos G, Liu R, Zou W. Inhibitory B7 family members in human ovarian carcinoma. Advances in Experimental Medicine and Biology. 622: 261-71. PMID 18546634 DOI: 10.1007/978-0-387-68969-2_21  0.36
2008 Barnett BG, Rüter J, Kryczek I, Brumlik MJ, Cheng PJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. Regulatory T cells: a new frontier in cancer immunotherapy. Advances in Experimental Medicine and Biology. 622: 255-60. PMID 18546633 DOI: 10.1007/978-0-387-68969-2-20  0.36
2008 Brumlik MJ, Daniel BJ, Waehler R, Curiel DT, Giles FJ, Curiel TJ. Trends in immunoconjugate and ligand-receptor based targeting development for cancer therapy Expert Opinion On Drug Delivery. 5: 87-103. PMID 18095930 DOI: 10.1517/17425247.5.1.87  0.36
2007 Wei S, Daniel BJ, Brumlik MJ, Burow ME, Zou W, Khan IA, Wadsworth S, Siekierka J, Curiel TJ. Drugs designed to inhibit human p38 mitogen-activated protein kinase activation treat Toxoplasma gondii and Encephalitozoon cuniculi infection. Antimicrobial Agents and Chemotherapy. 51: 4324-8. PMID 17923491 DOI: 10.1128/AAC.00680-07  0.36
2007 Lacey MR, Brumlik MJ, Yenni RE, Burow ME, Curiel TJ. Toxoplasma gondii expresses two mitogen-activated protein kinase genes that represent distinct protozoan subfamilies. Journal of Molecular Evolution. 64: 4-14. PMID 17160647 DOI: 10.1007/s00239-005-0197-x  0.36
2007 Rüter J, Barnett BG, Kryczek I, Brumlik MJ, Daniel BJ, Coukos G, Zou W, Curiel TJ. T-Regulatory Cell Manipulation in Tumor Immunotherapy Cancer Vaccines and Tumor Immunity. 189-204. DOI: 10.1002/9780470170113.ch12  0.36
2006 Barnett BG, Ruter J, Brumlik MJ, Kryczek I, Cheng PJ, Zou W, Curiel TJ. A phase II trial of denileukin diftitox to treat refractory advanced-stage ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2506. PMID 27954747 DOI: 10.1200/jco.2006.24.18_suppl.2506  0.36
2006 Salvo VA, Boué SM, Fonseca JP, Elliott S, Corbitt C, Collins-Burow BM, Curiel TJ, Srivastav SK, Shih BY, Carter-Wientjes C, Wood CE, Erhardt PW, Beckman BS, McLachlan JA, Cleveland TE, et al. Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 7159-64. PMID 17145841 DOI: 10.1158/1078-0432.Ccr-06-1426  0.36
2006 Kryczek I, Zou L, Rodriguez P, Zhu G, Wei S, Mottram P, Brumlik M, Cheng P, Curiel T, Myers L, Lackner A, Alvarez X, Ochoa A, Chen L, Zou W. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma. The Journal of Experimental Medicine. 203: 871-81. PMID 16606666 DOI: 10.1084/Jem.20050930  0.36
2006 Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, et al. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Molecular Endocrinology (Baltimore, Md.). 20: 971-83. PMID 16410316 DOI: 10.1210/Me.2004-0075  0.36
2005 Barnett B, Kryczek I, Cheng P, Zou W, Curiel TJ. Regulatory T cells in ovarian cancer: biology and therapeutic potential. American Journal of Reproductive Immunology (New York, N.Y. : 1989). 54: 369-77. PMID 16305662 DOI: 10.1111/j.1600-0897.2005.00330.x  0.36
2005 Wei S, Kryczek I, Zou L, Daniel B, Cheng P, Mottram P, Curiel T, Lange A, Zou W. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Research. 65: 5020-6. PMID 15958543 DOI: 10.1158/0008-5472.CAN-04-4043  0.36
2005 Korokhov N, de Gruijl TD, Aldrich WA, Triozzi PL, Banerjee PT, Gillies SD, Curiel TJ, Douglas JT, Scheper RJ, Curiel DT. High efficiency transduction of dendritic cells by adenoviral vectors targeted to DC-SIGN. Cancer Biology & Therapy. 4: 289-94. PMID 15753654 DOI: 10.4161/Cbt.4.3.1499  0.36
2005 Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, et al. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Research. 65: 465-72. PMID 15695388  0.36
2004 Zou L, Barnett B, Safah H, Larussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ, Zou W. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Research. 64: 8451-5. PMID 15548717 DOI: 10.1158/0008-5472.CAN-04-1987  0.36
2004 Brumlik MJ, Wei S, Finstad K, Nesbit J, Hyman LE, Lacey M, Burow ME, Curiel TJ. Identification of a novel mitogen-activated protein kinase in Toxoplasma gondii. International Journal For Parasitology. 34: 1245-54. PMID 15491587 DOI: 10.1016/J.Ijpara.2004.07.007  0.36
2004 Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine. 10: 942-9. PMID 15322536 DOI: 10.1038/Nm1093  0.36
2004 Curiel TJ, Cheng P, Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, Wei S, Zou L, Kryczek I, Hoyle G, Lackner A, Carmeliet P, Zou W. Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Research. 64: 5535-8. PMID 15313886 DOI: 10.1158/0008-5472.Can-04-1272  0.36
2004 Weldon CB, Elliott S, Zhu Y, Clayton JL, Curiel TJ, Jaffe BM, Burow ME. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Surgery. 136: 346-54. PMID 15300201 DOI: 10.1016/J.Surg.2004.05.010  0.36
2004 Curiel TJ, Morris C, Brumlik M, Landry SJ, Finstad K, Nelson A, Joshi V, Hawkins C, Alarez X, Lackner A, Mohamadzadeh M. Peptides identified through phage display direct immunogenic antigen to dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 172: 7425-31. PMID 15187120 DOI: 10.4049/Jimmunol.172.12.7425  0.36
2004 Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. International Journal of Oncology. 24: 1473-80. PMID 15138590 DOI: 10.3892/Ijo.24.6.1473  0.36
2003 Bennouna S, Bliss SK, Curiel TJ, Denkers EY. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. Journal of Immunology (Baltimore, Md. : 1950). 171: 6052-8. PMID 14634118 DOI: 10.4049/Jimmunol.171.11.6052  0.36
2003 Knutson KL, Curiel TJ, Salazar L, Disis ML. Immunologic principles and immunotherapeutic approaches in ovarian cancer. Hematology/Oncology Clinics of North America. 17: 1051-73. PMID 12959191 DOI: 10.1016/S0889-8588(03)00064-9  0.36
2003 Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P, Krzysiek R, Knutson KL, Daniel B, Zimmermann MC, David O, Burow M, Gordon A, Dhurandhar N, Myers L, et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nature Medicine. 9: 562-7. PMID 12704383 DOI: 10.1038/Nm863  0.36
2002 Lai R, McDonnell TJ, O'Connor SL, Medeiros LJ, Oudat R, Keating M, Morgan MB, Curiel TJ, Ford RJ. Establishment and characterization of a new mantle cell lymphoma cell line, Mino Leukemia Research. 26: 849-855. PMID 12127561 DOI: 10.1016/S0145-2126(02)00013-9  0.36
2002 Wei S, Marches F, Borvak J, Zou W, Channon J, White M, Radke J, Cesbron-Delauw MF, Curiel TJ. Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis. Infection and Immunity. 70: 1750-60. PMID 11895936  0.36
2001 Zou W, Machelon V, Coulomb-L'Hermin A, Borvak J, Nome F, Isaeva T, Wei S, Krzysiek R, Durand-Gasselin I, Gordon A, Pustilnik T, Curiel DT, Galanaud P, Capron F, Emilie D, ... Curiel TJ, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nature Medicine. 7: 1339-46. PMID 11726975 DOI: 10.1038/Nm1201-1339  0.36
1998 Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy. Biochemical and Biophysical Research Communications. 252: 686-90. PMID 9837767 DOI: 10.1006/Bbrc.1998.9685  0.36
1996 Connick E, Marr DG, Zhang XQ, Clark SJ, Saag MS, Schooley RT, Curiel TJ. HIV-specific cellular and humoral immune responses in primary HIV infection. Aids Research and Human Retroviruses. 12: 1129-40. PMID 8844017 DOI: 10.1089/Aid.1996.12.1129  0.36
1995 Finkel TH, Tudor-Williams G, Banda NK, Cotton MF, Curiel T, Monks C, Baba TW, Ruprecht RM, Kupfer A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes Nature Medicine. 1: 129-134. PMID 7585008 DOI: 10.1038/nm0295-129  0.36
1994 Cook DR, Maxwell IH, Glode LM, Maxwell F, Stevens JO, Purner MB, Wagner E, Curiel DT, Curiel TJ. Gene therapy for B-cell lymphoma in a SCID mouse model using an immunoglobulin-regulated diphtheria toxin gene delivered by a novel adenovirus-polylysine conjugate. Cancer Biotherapy. 9: 131-41. PMID 7812362 DOI: 10.1089/cbr.1994.9.131  0.36
1993 McFarland EJ, Curiel TJ, Schoen DJ, Rosandich ME, Schooley RT, Kuritzkes DR. Cytotoxic T lymphocyte lines specific for human immunodeficiency virus type 1 Gag and reverse transcriptase derived from a vertically infected child. The Journal of Infectious Diseases. 167: 719-23. PMID 7680062 DOI: 10.1093/Infdis/167.3.719  0.36
1993 Curiel TJ, Wong JT, Gorczyca PF, Schooley RT, Walker BD. CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. Aids Research and Human Retroviruses. 9: 61-8. PMID 7678973 DOI: 10.1089/Aid.1993.9.61  0.36
1992 Harrison GS, Long CJ, Curiel TJ, Maxwell F, Maxwell IH. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Human Gene Therapy. 3: 461-9. PMID 1329991 DOI: 10.1089/hum.1992.3.5-461  0.36
Show low-probability matches.